Geipel, A.* ; Seiz, P.L.* ; Niekamp, H.* ; Neumann-Fraune, M.* ; Zhang, K. ; Kaiser, R.* ; Protzer, U. ; Gerlich, W.H.* ; Glebe, D.* ; HOPE Consortium (*)
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine.
Antivir. Ther. (Lond.) 20, 779-787 (2016)
Corzillius, M.* ; Mühlberger, N. ; Sroczynski, G.* ; Jaeger, H.* ; Wasem, J.* ; Siebert, U.*
Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV.
Antivir. Ther. (Lond.) 9, 27-36 (2004)